4.4 Article

Gene Expression and Single Nucleotide Polymorphism Array Analyses of Spindle Cell Lipomas and Conventional Lipomas with 13q14 Deletion

期刊

GENES CHROMOSOMES & CANCER
卷 50, 期 8, 页码 619-632

出版社

WILEY
DOI: 10.1002/gcc.20884

关键词

-

资金

  1. The Swedish Cancer Society
  2. The Swedish Research Council
  3. The Royal Physiographic Society in Lund

向作者/读者索取更多资源

Spindle cell lipomas (SCL) are circumscribed, usually s.c. tumors that typically occur on the posterior neck, shoulder, and back of middle aged men. Cytogenetically, almost all SCL are characterized by deletions of chromosome arm 13q, often in combination with loss of 16q. Deletions of 13q are seen also in approximately 15% of conventional lipomas. Through single nucleotide polymorphism (SNP) array analyses, we identified two minimal deleted regions (MDR) in 13q14 in SCL. In MDR1, four genes were located, including the tumor suppressor gene RB1. MDR1 in SCL overlapped with the MDR detected in conventional lipomas with 13q14 deletion. In MDR2 in SCL there were 34 genes and the two microRNA (miRNA) genes miR-15a and miR-16-1. Global gene expression analysis was used to study the impact of the deletions on genes mapping to the two SCL-associated MDR. Five genes (C13orf1, DHRS12, ATP7B, ALG11, and VPS36) in SCL and one gene (C13orf1) in conventional lipomas with 13q-deletions were found to be significantly underexpressed compared with control tissues. Quantitative real-time PCR showed that miR-16-1 was expressed at lower levels in SCL than in the control samples. No mutations were found at sequencing of RB1, miR-15a, and miR-16-1. Our findings further delineate the target region for the 13q deletion in SCL and conventional lipomas and show that the deletions are associated with down-regulated expression of several genes, notably C13orf1, which was the only gene to be significantly down-regulated in both tumor types. (C) 2011 Wiley-Liss, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Deep sequencing of myxoinflammatory fibroblastic sarcoma

Elsa Arbajian, Jakob Hofvander, Linda Magnusson, Fredrik Mertens

GENES CHROMOSOMES & CANCER (2020)

Article Pathology

PHF1 fusions cause distinct gene expression and chromatin accessibility profiles in ossifying fibromyxoid tumors and mesenchymal cells

Jakob Hofvander, Vickie Y. Jo, Christopher D. M. Fletcher, Florian Puls, Uta Flucke, Jenny Nilsson, Linda Magnusson, Fredrik Mertens

MODERN PATHOLOGY (2020)

Article Hematology

13q12.2 deletions in acute lymphoblastic leukemia lead to upregulation of FLT3 through enhancer hijacking

Minjun Yang, Setareh Safavi, Eleanor L. Woodward, Nicolas Duployez, Linda Olsson-Arvidsson, Jonas Ungerback, Mikael Sigvardsson, Marketa Zaliova, Jan Zuna, Thoas Fioretos, Bertil Johansson, Karolin H. Nord, Kajsa Paulsson

Article Pathology

Loss ofNF2defines a genetic subgroup ofnon-FOS-rearranged osteoblastoma

Karim H. Saba, Louise Cornmark, Jakob Hofvander, Linda Magnusson, Jenny Nilsson, Hilda van den Bos, Diana C. J. Spierings, Floris Foijer, Johan Staaf, Otte Brosjo, Vaiyapuri P. Sumathi, Suk Wai Lam, Karoly Szuhai, Judith V. M. G. Bovee, Michal Kovac, Daniel Baumhoer, Emelie Styring, Karolin H. Nord

JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2020)

Article Cell Biology

Comparative cytological and histological assessment of 828 primary soft tissue and bone lesions, and proposal for a system for reporting soft tissue cytopathology

Jan Koster, Iman Ghanei, Henryk A. Domanski

Summary: FNA cytology is a suitable tool for assessing the malignant potential of sampled soft tissue/bone lesions, but is less effective than CNB in defining the correct histopathological entity. A standardized reporting system may enhance the clinical management of patients with soft tissue tumors primarily examined by FNA cytology.

CYTOPATHOLOGY (2021)

Article Oncology

Genomic and transcriptomic characterization of desmoplastic small round cell tumors

Saskia Sydow, Yvonne M. H. Versleijen-Jonkers, Magnus Hansson, Anke E. M. van Erp, Melissa H. S. Hillebrandt-Roeffen, Winette T. A. van Der Graaf, Paul Piccinelli, Pehr Rissler, Uta E. Flucke, Fredrik Mertens

Summary: Desmoplastic small round cell tumor (DSRCT) is a highly aggressive soft tissue tumor primarily affecting children and young adults, with most cases displaying a pathognomonic gene fusion. Copy number alterations were found in all DSRCT patient samples, with common imbalances including gain of chromosomes/chromosome arms 1/1q and 5/5p and loss of 6/6q and 16/16q. Global gene expression analysis revealed a distinct transcriptomic profile with enrichment of genes involved in neural differentiation, and two genes, GJB2 and GAL, showed potential as diagnostic markers at the protein level in DSRCT.

GENES CHROMOSOMES & CANCER (2021)

Article Oncology

Amplification of ERBB2 (HER2) in embryonal rhabdomyosarcoma: A potential treatment target in rare cases?

Shamik Mitra, Saskia Sydow, Linda Magnusson, Paul Piccinelli, Lisa Tornudd, Ingrid Ora, Gustaf Ljungman, Johanna Sandgren, David Gisselsson, Fredrik Mertens

Summary: The ERBB2 gene is frequently amplified and overexpressed in breast cancer, which can be targeted with drugs like trastuzumab. In children, especially in alveolar and embryonal rhabdomyosarcoma, increased expression of ERBB2 can be used as a treatment target.

GENES CHROMOSOMES & CANCER (2022)

Article Medicine, Research & Experimental

The diagnostic utility of DNA copy number analysis of core needle biopsies from soft tissue and bone tumors

Jan Koster, Paul Piccinelli, Linda Arvidsson, Fredrik Vult von Steyern, Camila Bedeschi Rego De Mattos, Martin Almquist, Jenny Nilsson, Linda Magnusson, Fredrik Mertens

Summary: Morphologic and immunohistochemical analysis of preoperative core needle biopsies is crucial for the management of soft tissue and bone tumors. The use of single nucleotide polymorphism array analysis can provide diagnostic information about copy number aberrations.

LABORATORY INVESTIGATION (2022)

Article Oncology

Inactivation of RB1, CDKN2A, and TP53 have distinct effects on genomic stability at side-by-side comparison in karyotypically normal cells

Natalie Andersson, Karim H. Saba, Linda Magnusson, Jenny Nilsson, Jenny Karlsson, Karolin H. Nord, David Gisselsson

Summary: Chromosomal instability is a common feature in malignant tumors, and previous studies have shown that inactivation of RB1, CDKN2A, and TP53 can contribute to this instability. In this study, the researchers used CRISPR-Cas9 technology to individually knock out these genes in immortalized cells and observed their effects on chromosomal stability over time. The results revealed that RB1 and CDKN2A loss had minimal impact on chromosomal stability, while TP53 loss led to massive chromosomal alterations. These findings suggest that RB1 and CDKN2A alone are not sufficient to cause detectable aneuploid clones, while TP53 inactivation can result in chromosomal instability and evolution.

GENES CHROMOSOMES & CANCER (2023)

Review Cell Biology

Pitfalls in soft tissue cytopathology

Bharat Rekhi, Xiaohua Qian, Henryk A. Domanski, Jerzy Klijanienko, Andrew Field

Summary: Fine needle aspiration biopsy (FNAB) is an effective method for evaluating suspicious soft tissue masses, but accurately subtyping primary soft tissue tumors can be difficult. This review discusses the diagnostic challenges in soft tissue cytopathology, including pitfalls and strategies for overcoming these challenges by integrating clinical details, key cytomorphological features, and ancillary techniques.

CYTOPATHOLOGY (2023)

Editorial Material Cell Biology

Cytology of a parietal swelling in a 52-year-old man

Elwira Bakula-Zalewska, Henryk A. Domanski

CYTOPATHOLOGY (2023)

Review Pathology

The Small Round Cell Sarcomas Complexities and Desmoplastic Presentation

Henryk A. Domanski

Summary: This article summarizes the cytomorphologic criteria and presents rare and divergent cytological features of small round cell sarcomas (SRCSs). Accurate diagnosis requires careful assessment of clinical presentation, cytological features, immunohistochemical patterns, and molecular alterations. Understanding the complexity of cytological features and being aware of rare findings that differ from established diagnostic criteria are essential for correct diagnosis.

ACTA CYTOLOGICA (2022)

Article Pathology

Inflammatory Leiomyosarcoma and Histiocyte-rich Rhabdomyoblastic Tumor: a clinicopathological, immunohistochemical and genetic study of 13 cases, with a proposal for reclassification as Inflammatory Rhabdomyoblastic Tumor

Jeffrey M. Cloutier, Gregory W. Charville, Fredrik Mertens, William Sukov, Karen Fritchie, Kyle D. Perry, Mark Edgar, Ross A. Rowsey, Andrew L. Folpe

Summary: Inflammatory leiomyosarcoma (ILMS) and histiocyte-rich rhabdomyoblastic tumor (HRRMT) share similar morphological features and gene expression profiles, with both types of tumors showing indolent behavior and primarily affecting young to middle-aged males in the deep soft tissues of the extremities. The proposal to reclassify ILMS and HRRMT as inflammatory rhabdomyoblastic tumor reflects the relationship between these two rare soft tissue tumors and their distinctive clinical characteristics.

MODERN PATHOLOGY (2021)

Article Pathology

NTRK fusions in osteosarcoma are rare and non-functional events

Baptiste Ameline, Karim H. Saba, Michal Kovac, Linda Magnusson, Olaf Witt, Stefan Bielack, Michaela Nathrath, Karolin H. Nord, Daniel Baumhoer

JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2020)

暂无数据